help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1391
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Lastra, G.
Right arrow Articles by Sowers, J. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lastra, G.
Right arrow Articles by Sowers, J. R.
Endocrinology Vol. 150, No. 6 2561-2568
Copyright © 2009 by The Endocrine Society

Direct Renin Inhibition Improves Systemic Insulin Resistance and Skeletal Muscle Glucose Transport in a Transgenic Rodent Model of Tissue Renin Overexpression

Guido Lastra1, Javad Habibi1, Adam T. Whaley-Connell, Camila Manrique, Melvin R. Hayden, Jenna Rehmer, Kamlesh Patel, Carlos Ferrario and James R. Sowers

Department of Internal Medicine (G.L., J.H., A.T.W.-C., C.M., M.R.H., J.R., K.P., J.R.S.), University of Missouri-Columbia School of Medicine, Columbia, Missouri 65212; Departments of Physiology and Pharmacology (J.R.S.), Diabetes Cardiovascular Center (G.L., J.H., A.T.W.-C., C.M., M.R.H., J.R., K.P., J.R.S.), Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157; and Harry S. Truman Veterans Affairs Medical Center (A.T.W.-C., C.F., J.R.S.), Columbia, Missouri 65201

Address all correspondence and requests for reprints to: James R. Sowers, M.D., Professor of Medicine, Physiology, and Pharmacology, Room D109 Health Sciences Center, Diabetes Center, 1 Hospital Drive, University of Missouri, Columbia, Missouri 65212. E-mail: sowersj{at}health.missouri.edu.

Renin is the rate-limiting enzyme in renin-angiotensin system (RAS) activation. We sought to determine the impact of renin inhibition on whole-body insulin sensitivity and skeletal muscle RAS, oxidative stress, insulin signaling, and glucose transport in the transgenic TG(mRen2)27 rat (Ren2), which manifests increased tissue RAS activity, elevated serum aldosterone, hypertension, and insulin resistance. Young (aged 6–9 wk) Ren2 and age-matched Sprague Dawley control rats were treated with aliskiren [50 mg/kg · d, ip] or placebo for 21 d and administered an ip glucose tolerance test. Insulin metabolic signaling and 2-deoxyglucose uptake in soleus muscle were examined in relation to tissue renin-angiotensin-aldosterone system [angiotensin (Ang) II, mineralocorticoid receptor (MR), and Ang type I receptor (AT1R)] and measures of oxidative stress as well as structural changes evaluated by light and transmission electron microscopy. Ren2 rats demonstrated systemic insulin resistance with decreased skeletal muscle insulin metabolic signaling and glucose uptake. This was associated with increased Ang II, MR, AT1R, oxidative stress, and reduced tyrosine insulin receptor substrate-1 phosphorylation, protein kinase B/(Akt) phosphorylation and glucose transporter-4 immunostaining. The Ren2 also demonstrated perivascular fibrosis and mitochondrial remodeling. Renin inhibition improved systemic insulin sensitivity, insulin metabolic signaling, and glucose transport along with normalization of Ang II, AT1R, and MR levels, oxidative stress markers, fibrosis, and mitochondrial structural abnormalities. Our data suggest that renin inhibition improves systemic insulin sensitivity, skeletal muscle insulin metabolic signaling, and glucose transport in Ren2 rats. This is associated with reductions in skeletal muscle tissue Ang II, AT1R, and MR expression; oxidative stress; fibrosis; and mitochondrial abnormalities.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society